AbbVie annual asset turnover
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AbbVie Asset Turnover Growth & History (ABBV)
AbbVie's asset turnover was 0.45 for fiscal 2025.
View full AbbVie company overviewAbbVie annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.45 | 0.04 | +8.87% |
| 2024 | 2024-12-31 | 0.42 | 0.02 | +5.11% |
| 2023 | 2023-12-31 | 0.40 | −0.01 | −2.39% |
| 2022 | 2022-12-31 | 0.41 | 0.03 | +7.56% |
| 2021 | 2021-12-31 | 0.38 | −0.00 | −1.02% |
| 2020 | 2020-12-31 | 0.38 | −0.07 | −14.71% |
| 2019 | 2019-12-31 | 0.45 | −0.06 | −10.97% |
| 2018 | 2018-12-31 | 0.50 | 0.09 | +22.10% |
| 2017 | 2017-12-31 | 0.41 | −0.02 | −4.20% |
| 2016 | 2016-12-31 | 0.43 | −0.14 | −24.16% |
| 2015 | 2015-12-31 | 0.57 | −0.14 | −19.38% |
| 2014 | 2014-12-31 | 0.70 | 0.04 | +5.28% |
| 2013 | 2013-12-31 | 0.67 | — | — |
AbbVie quarterly asset turnover
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.47 | 0.05 | +13.15% |
| Q1 2026 | 2026-03-31 | 0.46 | 0.06 | +14.49% |
| Q4 2025 | 2025-12-31 | 0.45 | 0.04 | +8.87% |
| Q3 2025 | 2025-09-30 | 0.43 | 0.03 | +8.30% |
| Q2 2025 | 2025-06-30 | 0.42 | 0.02 | +5.36% |
| Q1 2025 | 2025-03-31 | 0.40 | 0.02 | +4.85% |
| Q4 2024 | 2024-12-31 | 0.42 | 0.02 | +5.11% |
| Q3 2024 | 2024-09-30 | 0.40 | −0.00 | −0.04% |
| Q2 2024 | 2024-06-30 | 0.40 | −0.01 | −1.38% |
| Q1 2024 | 2024-03-31 | 0.38 | −0.02 | −6.04% |
| Q4 2023 | 2023-12-31 | 0.40 | −0.01 | −2.39% |
| Q3 2023 | 2023-09-30 | 0.40 | −0.00 | −0.29% |
| Q2 2023 | 2023-06-30 | 0.40 | 0.01 | +2.11% |
| Q1 2023 | 2023-03-31 | 0.41 | 0.02 | +5.77% |
| Q4 2022 | 2022-12-31 | 0.41 | 0.03 | +7.56% |
| Q3 2022 | 2022-09-30 | 0.40 | 0.03 | +7.80% |
| Q2 2022 | 2022-06-30 | 0.39 | 0.03 | +9.06% |
| Q1 2022 | 2022-03-31 | 0.39 | −0.03 | −7.00% |
| Q4 2021 | 2021-12-31 | 0.38 | −0.00 | −1.02% |
| Q3 2021 | 2021-09-30 | 0.37 | −0.02 | −4.94% |
| Q2 2021 | 2021-06-30 | 0.36 | 0.01 | +3.03% |
| Q1 2021 | 2021-03-31 | 0.42 | −0.04 | −9.77% |
| Q4 2020 | 2020-12-31 | 0.38 | −0.07 | −14.71% |
| Q3 2020 | 2020-09-30 | 0.39 | −0.13 | −25.69% |
| Q2 2020 | 2020-06-30 | 0.35 | −0.20 | −36.18% |
| Q1 2020 | 2020-03-31 | 0.46 | −0.06 | −11.09% |
| Q4 2019 | 2019-12-31 | 0.45 | −0.06 | −10.97% |
| Q3 2019 | 2019-09-30 | 0.52 | 0.05 | +9.75% |
| Q2 2019 | 2019-06-30 | 0.55 | 0.07 | +14.17% |
| Q1 2019 | 2019-03-31 | 0.52 | 0.08 | +18.03% |
| Q4 2018 | 2018-12-31 | 0.50 | 0.09 | +22.10% |
| Q3 2018 · Sep 30 | 2018-09-30 | 0.48 | 0.07 | +18.42% |
| Q2 2018 | 2018-06-30 | 0.48 | 0.08 | +20.88% |
| Q1 2018 | 2018-03-31 | 0.44 | −0.00 | −0.12% |
| Q4 2017 | 2017-12-31 | 0.41 | −0.02 | −4.20% |
| Q3 2017 | 2017-09-30 | 0.40 | −0.01 | −3.13% |
| Q2 2017 | 2017-06-30 | 0.40 | −0.01 | −2.66% |
| Q1 2017 | 2017-03-31 | 0.44 | −0.15 | −25.72% |
| Q4 2016 | 2016-12-31 | 0.43 | −0.14 | −24.16% |
| Q3 2016 | 2016-09-30 | 0.42 | −0.11 | −21.00% |
| Q2 2016 | 2016-06-30 | 0.41 | −0.10 | −19.23% |
| Q1 2016 | 2016-03-31 | 0.59 | −0.15 | −19.92% |
| Q4 2015 | 2015-12-31 | 0.57 | −0.14 | −19.38% |
| Q3 2015 | 2015-09-30 | 0.53 | −0.17 | −23.96% |
| Q2 2015 | 2015-06-30 | 0.51 | −0.17 | −25.13% |
| Q1 2015 | 2015-03-31 | 0.74 | 0.06 | +8.34% |
| Q4 2014 | 2014-12-31 | 0.70 | 0.04 | +5.28% |
| Q3 2014 | 2014-09-30 | 0.69 | — | — |
| Q2 2014 | 2014-06-30 | 0.68 | — | — |
| Q1 2014 | 2014-03-31 | 0.68 | — | — |
| Q4 2013 | 2013-12-31 | 0.67 | — | — |
AbbVie asset turnover trends
Over the last five fiscal years, AbbVie's asset turnover increased from 0.38 to 0.45, a change of 0.07. The latest reported quarter, Q2 2026, shows 0.47.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AbbVie source filings ↗Community posts
FDA clears at-home Skyrizi induction for Crohn’s disease
AbbVie ($ABBV) received FDA approval for subcutaneous induction dosing of Skyrizi in adults with moderately to severely active Crohn’s disease. Patients can now begin treatment at home using an on-body injector, extending that delivery opti ...
AbbVie meets pivotal hidradenitis endpoint with lutikizumab
AbbVie ($ABBV) reported that lutikizumab met the main endpoint and all eight ranked secondary endpoints in the Phase 3 INTREPID trial for moderate to severe hidradenitis suppurativa. At week 16, 31.4% of treated patients achieved HiSCR75, c ...
AbbVie’s menstrual-migraine study meets its primary and all ranked secondary goals
AbbVie ($ABBV) reported positive Phase 3 LUNA results for atogepant in menstrual migraine. The study enrolled 468 women and evaluated treatment across three menstrual cycles. Migraine days during the assessed menstrual period fell by 1.20 d ...
